Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 4/5 cls
ArQule (ARQL) Stanford Group Hanzhong Li New Buy 6% $7.92
Li set an $11 target. He believes ARQL's ARQ 197 to treat cancer has blockbuster potential among kinase inhibitors in development. The company plans to begin

Read the full 491 word article

How to gain access

Continue reading with a
two-week free trial.